PTPRC and breast carcinoma: To address to what extent the presence of the tumor vascular targeting anti-ED-A antibodies was able to attract immune cells to the tumor tissue, we analyzed the amount of leukocytes in breast carcinomas from TRX and TRX-EDA vaccinated mice, by immunostaining for the pan-leukocyte marker CD45.